IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis

PloS One
Pedro J AlcoleaVicente Larraga

Abstract

Leishmania infantum causes zoonotic visceral leishmaniasis (ZVL) in the Mediterranean basin and South America. The parasite has been shown to co-infect HIV patients and an outbreak in central Spain was reported in the last decade. Therfore, ZVL is a public health problem, dogs being the parasite's reservoir. We have developed a DNA vaccine based on the L. infantum activated protein kinase A receptor (LACK) using different plasmid vectors and vaccinia virus strains as vehicles. Recently, we have generated an antibiotic resistance marker-free plasmid vector called pPAL. Homologous pPAL-LACK prime-boost vaccination protects Beagle dogs as well as a heterologous plasmid-virus regime. For both reasons, pPAL improves safety. IL12 was described to trigger Th1 response through IFN-γ production in infected dogs, being a good candidate for cytokine therapy in conventional treatment-unresponsive dogs. Herein, we report a complete protection study in dogs through inoculation of genes encoding for the p35 and p40 subunits which compose canine IL12 in combination with the LACK gene. A homologous plasmid-plasmid regime using independent pPAL constructs for each gene was inoculated in a 15-day interval. The infectious challenge using L. infant...Continue Reading

References

May 1, 1989·The Journal of Emergency Medicine·K L Keller, W J Koenig
Jan 1, 1983·Methods in Enzymology·D Hanahan, M Meselson
Jan 1, 1980·Transactions of the Royal Society of Tropical Medicine and Hygiene·T V BarrettI A Sherlock
Sep 1, 1995·The American Journal of Tropical Medicine and Hygiene·E M CarvalhoH Rocha
Jan 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·M I JiménezJ Alvar
May 1, 1993·Acta Tropica·S F Moody
Apr 1, 1997·Clinical Microbiology Reviews·J AlvarJ Moreno
Aug 1, 1998·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A Ribeiro-de-JesusE M Carvalho
Apr 27, 2000·Parasitology Today·I L MaurícioM A Miles
May 30, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M L GuimarãesM G Morgado
Jan 5, 2002·Medical Microbiology and Immunology·D WoldayS Britton
Nov 5, 2002·Nature Reviews. Immunology·David Sacks, Nancy Noben-Trauth
Aug 24, 2007·FEMS Immunology and Medical Microbiology·Parul TripathiSita Naik
Aug 10, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A ArceF Vilas
Apr 20, 2014·Veterinary Medicine International·Claudia MomoRosemeri de Oliveira Vasconcelos
Apr 21, 2016·Parasitology·Shazia HoseinLaia Solano-Gallego

❮ Previous
Next ❯

Datasets Mentioned

BETA
U49085
U49100

Methods Mentioned

BETA
electrophoresis
PCR
Assay
ELISA

Software Mentioned

Microplate Manager

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.